Related Experiment Video

Updated: Nov 19, 2025

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

3.4K

Photodynamic Therapy and Medicare Expenditures

Rachel K Lim1, Martin A Weinstock1,2

  • 1Brown University, Providence, Rhode Island.

JAMA Dermatology
|January 27, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

An In Vitro Approach to Photodynamic Therapy
04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

9.1K
Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal
07:24

Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal

Published on: September 12, 2025

269

Related Experiment Videos

Last Updated: Nov 19, 2025

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

3.4K
An In Vitro Approach to Photodynamic Therapy
04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

9.1K
Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal
07:24

Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal

Published on: September 12, 2025

269

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

86
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
86

Articles linked to this work by shared authors, journal, and citation graph.

The impact on airborne isolation duration utilizing GeneXpert versus acid-fast bacilli smears to guide discontinuation among individuals with suspected pulmonary tuberculosis: a systematic review and meta-analysis.

Infection control and hospital epidemiology·2026

A qualitative study of the impact of the COVID-19 pandemic on healthcare access and service delivery for people living with chronic obstructive pulmonary disease and asthma.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026

Disparities in Initial Usage of Direct-to-Patient Teledermatology: A Retrospective Observational Study.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2026

Correction: Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma education.

Frontiers in medicine·2026

Correction: Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomes.

Frontiers in medicine·2026

Identification of Risk Factors for Acral Melanoma in US Veterans.

JAMA dermatology·2026

High-Dose Oral Vitamin D for Toxic Effects of the Skin Associated With Chemotherapy and Radiation.

JAMA dermatology·2026

Tuberculosis-Related Outcomes in Dermatologic Patients Receiving Systemic Therapy: A Systematic Review and Meta-Analysis.

JAMA dermatology·2026

Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma.

JAMA dermatology·2026

ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma Recurrence.

JAMA dermatology·2026

Topical Preparations for Moderate to Severe Rosacea Treatment: A Systematic Review and Network Meta-Analysis.

JAMA dermatology·2026

IRA Reforms To Medicare Part D Reinsurance Were Associated With Plan Exits And Higher Premiums, 2024-25.

Health affairs (Project Hope)·2026

Individual-Tree Modeling System for Projecting Stem and Heartwood in Clonal Teak Plantations in Eastern Amazon.

Plants (Basel, Switzerland)·2026

Inflation Reduction Act Changes To Part D Plan Design: Lower Premiums, Higher Deductibles, And Some Smaller Formularies.

Health affairs (Project Hope)·2026

Understanding and Neutralizing the Expense Prediction Bias: The Role of Accessibility, Typicality, and Skewness.

JMR, Journal of marketing research·2026

Friedewald and Martin-Hopkins formulae for estimating low-density lipoprotein cholesterol in a Malagasy population.

African journal of laboratory medicine·2026

Cost-effectiveness analysis of oral semaglutide versus subcutaneous dulaglutide in patients with type 2 diabetes mellitus: A Markov model study.

Diabetes research and clinical practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us